Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors

Human Gene Therapy

Volumn 13, Issue 18, 2002, Pages 2113-2124

  Schmeisser, Falko ^a   Donohue, Megan ^a   Weir, Jerry P ^a,b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Center for Biologics Evaluation/Res   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; DOXYCYCLINE; TETRACYCLINE; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; EUKARYOTE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE INDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; PROMOTER REGION; REPRESSOR GENE; VIRUS REPLICATION;

ANIMALS; DOXYCYCLINE; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; HELA CELLS; HUMANS; PC12 CELLS; PROMOTER REGIONS (GENETICS); RATS; SIMPLEXVIRUS; TETRACYCLINE; TRANS-ACTIVATION (GENETICS); VIRUS REPLICATION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; EUKARYOTA; SIMPLEXVIRUS;

EID: 0036978696     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303402320987815     Document Type: Article

References (52)

1. ACE, C.I., MCKEE, T.A., RYAN, J.M., CAMERON, J.M., and PRESTON, C.M. (1989). Construction and characterization of a herpes simplex virus type 1 mutant unable to transactivate immediate-early gene expression. J. Virol. 63, 2260-2269.
2. AGHA-MOHAMMADI, S., and LOTZE, M.T. (2000). Regulatable systems: Applications in gene therapy and replicating viruses. J. Clin. Invest. 105, 1177-1183.
3. ANDREWS, P.W. (1984). Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103, 285-293.
4. ANDREWS, P.W., DAMJANOV, I., SIMON, D., BANTING, G.S., CARLIN, C., DRACOPOLI, N.C., and FOGH, J. (1984). Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2: Differentiation in vivo and in vitro. Lab. Invest. 50, 147-162.
5. BARON, U., SCHNAPPINGER, D., HELBL, V., GOSSEN, M., HILLEN, W., and BUJARD, H. (1999). Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc. Natl. Acad. Sci. U.S.A. 96, 1013-1018.
6. COSTANTINI, L.C., BAKOWSKA, J.C., BREAKEFIELD, X.O., and ISACSON, O. (2000). Gene therapy in the CNS. Gene Ther. 7, 93-109.
7. DELUCA, N.A., and SCHAFFER, P.A. (1987). Activities of herpes simplex type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res. 15, 4491-4511.
8. DELUCA, N.A., MCCARTHY, A.M., and SCHAFFER, P.A. (1985). Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56, 558-570.
9. FINK, D.J., DELUCA, N.A., YAMADA, M., WOLFE, D.P., and GLORIOSO, J.C. (2000). Design and application of HSV vectors for neuroprotection. Gene Ther. 7, 115-119.
10. FOTAKI, M.E., PINK, J.R., and MOUS, J. (1997). Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transfer. Gene Ther. 4, 901-908.
11. GINGRICH, J.R., and RODER, J. (1998). Inducible gene expression in the nervous system of transgenic mice. Annu. Rev. Neurosci. 21, 377-405.
12. GOINS, W.F., LEE, K.A., CAVALCOLI, J.D., O'MALLEY, M.E., DEKOSKY, S.T., FINK, D.J., and GLORIOSO, J.C. (1999). Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J. Virol. 73, 519-532.
13. GOSSEN, M., and BUJARD, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89, 5547-5551.
14. GOSSEN, M., FREUNDLIEB, S., BENDER, G., MULLER, G., HILLEN, W., and BUJARD, H. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
15. GREENE, L.A., and TISCHLER, A.S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 73, 2424-2428.
16. HABERMAN, R.P., MCCOWN, T.J., and SAMULSKI, R.J. (1998). Inducible long-term gene expression in brain with adeno-associated virus gene transfer. Gene Ther. 5, 1604-1611.
17. HAGMANN, M., GEORGIEV, O., SCHAFFNER, W., and DOUVILLE, P. (1995). Transcription factors interacting with herpes simplex virus alpha; gene promoters in sensory neurons. Nucleic Acids Res. 23, 4978-4985.
18. HARDING, T.C., GEDDES, B.J., MURPHY, D., KNIGHT, D., and UNEY, J.B. (1998). Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system. Nat. Biotechnol. 16, 553-555.
19. HO, D.Y., MCLAUGHLIN, J.R., and SAPOLSKY, R.M. (1996). Inducible gene expression from the defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Mol. Brain Res. 41, 200-209.
20. HSU, W.-L., and EVERETT, R.D. (2001). Human neuron-committed teratocarcinoma NT2 cell line has abnormal ND10 structures and is poorly infected by herpes simplex virus type 1. J. Virol. 75, 3819-3831.
21. JACOBSON, J.G., RUFFNER, K.L., KOSZ-VNENCHAK, M., HWANG, C.B.C., WOBBE, K.K., KNIPE, D.M., and COEN, D.M. (1993). Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia. J. Virol. 67, 6903-6908.
22. JOHNSON, P.A., MIYANOHARA, A., LEVINE, F., CAHILL, T., and FRIEDMANN, T. (1992). Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol. 66, 2952-2965.
23. KAFRI, T., VAN PRAAG, H., GAGE, F.H., and VERMA, I.M. (2000). Lentiviral vectors: Regulated gene expression. Mol. Ther. 1, 516-521.
24. KEMP, L.M., DENT, C.L., and LATCHMAN, D.S. (1990). Octamer motif mediates transcriptional repression of HSV immediate-early genes and octamer-containing cellular promoters in neuronal cells. Neuron 4, 215-222.
25. KESARI, S., RANDAZZO, B.P., VALYI-NAGY, T., HUANG, Q.S., BROWN, S.M., MACLEAN, A.R., LEE, V.M.-Y., TROJANOWSKI, J.Q., and FRASER, N.W. (1995). Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant. Lab. Invest. 73, 636-648.
26. KOSZ-VNENCHAK, M., JACOBSON, J., COEN, D.M., and KNIPE, D.M. (1993). Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J. Virol. 67, 5383-5393.
27. KRISKY, D.M., WOLFE, D., GOINS, W.F., MARCONI, P.C., RAMAKRISHNAN, R., MATA, M., ROUSE, R.J.D., FINK, D.J., and GLORIOSO, J.C. (1998). Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther. 5, 1593-1603.
28. LACHMANN, R.H., and EFSTATHIOU, S. (1997). Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system. J. Virol. 71, 3197-3207.
29. LATCHMAN, D.S. (2001). Gene delivery and gene therapy with herpes simplex virus-based vectors. Gene 264, 1-9.
30. MANSUY, I.M., and BUJARD, H. (2000). Tetracycline-regulated gene expression in the brain. Curr. Opin. Neurobiol. 10, 593-596.
31. NICHOL, P.F., CHANG, J.Y., JOHNSON, E.M., Jr., and OLIVO, P.D. (1996). Herpes simplex virus gene expression in neurons: Viral DNA synthesis is a critical regulatory event in the branch point between the lyric and latent pathways. J. Virol. 70, 5476-5486.
32. NO, D., YAO, T.-P., and EVANS, R.M. (1996). Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 93, 3346-3351.
33. OLIGINO, T., POLIANI, P.L., MARCONI, P., BENDER, M.A., SCHMIDT, M.C., FINK, D.J., and GLORIOSO, J.C. (1996). In vivo transgene activation from an HSV-based gene therapy vector by GAL4:VP16. Gene Ther. 3, 892-899.
34. OLIGINO, T., POLIANI, P.L., WANG, Y., TSAI, S.Y., O'MALLEY, B.W., FINK, D.J., and GLORIOSO, J.C. (1998). Drug inducible transgene expression in brain using a herpes simplex virus vector. Gene Ther. 5, 491-496.
35. PRESTON, C.M., MABBS, R., and NICHOLL, M.J. (1997). Construction and characterization of herpes simplex virus type 1 mutants with conditional defects in immediate early gene expression. Virology 229, 228-239.
36. RIVERA, V.M., CLACKSON, T., NATESAN, S., POLLOCK, R., AMARA, J.F., KEENAN, T., MAGARI, S.R., PHILLIPS, T., COURAGE, N.L., CERASOLI, F., Jr., HOLT, D.A., and GILMAN, M. (1996). A humanized system for pharmacologic control of gene expression. Nat. Med. 2, 1028-1032.
37. ROSSI, F.M.V., and BLAU, H.M. (1998). Recent advances in inducible gene expression systems. Curr. Opin. Biotechnol. 9, 451-456.
38. ROSSI, F.M.V., GUICHERIT, O.M., SPICHER, A., KRINGSTEIN, A.M., FATYOL, K., BLAKELY, B.T., and BLAU, H.M. (1998). Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat. Genet. 20, 389-393.
39. RUBENSTEIN, R., and PRICE, R.W. (1983). Replication of thymidine kinase deficient herpes simplex virus type 1 in neuronal cell culture: Infection of the PC12 cell. Arch. Virol. 78, 49-64.
40. SAMANIEGO, L.A., WU, N., and DELUCA, N.A. (1997). The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J. Virol. 71, 4614-4625.
41. SAMANIEGO, L.A., NEIDERHISER, L., and DELUCA, N.A. (1998). Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72, 3307-3320.
42. SHOKETT, P., DIFILIPPANTONIO, M., HELLMAN, N., and SCHATZ, D.G. (1995). A modified tetracycline-regulated system provides autoregulatory inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 92, 6522-6526.
43. SIMONATO, M., MANSERVIGI, R., MARCONI, P., and GLORIOSO, J. (2000). Gene transfer into neurones for the molecular analysis of behaviour: Focus on herpes simplex vectors. Trends Neurosci. 23, 183-190.
44. URLINGER, S., BARON, U., THELLMANN, M., HASAN, M.T., BUJARD, H., and HILLEN, W. (2000). Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. U.S.A. 97, 7963-7968.
45. WANG, M.J., FRIEDMANN, T., and JOHNSON, P.A. (1995). Differentiation of PCI2 cells by infection with an HSV-1 vector expressing nerve growth factor. Gene Ther. 2, 323-335.
46. WANG, Y., O'MALLEY, B.W., Jr., TSAI, S., and O'MALLEY, B.W. (1994). A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. U.S.A. 91, 8180-8184.
47. WEIR, J.P. (2001). Infection of human NT2 cells and differentiated NT-neurons with herpes simplex virus and replication-incompetent herpes simplex virus vectors. J. Neurovirol. 7, 43-51.
48. WEIR, J.P., and DACQUEL, E.J. (1995). Plasmid insertion vectors that facilitate construction of herpes simplex virus gene delivery vectors. Gene 154, 123-128.
49. WEIR, J.P., and ELKINS, K.L. (1993). Replication-incompetent herpesvirus vector delivery of an interferon a gene inhibits human immunodeficiency virus replication in human monocytes. Proc. Natl. Acad. Sci. U.S.A. 90, 9140-9144.
50. WEIR, J.P., STEFFY, K.R., and SETHNA, M. (1990). An insertion vector for the analysis of gene expression during herpes simplex virus infection. Gene 89, 271-274.
51. WILCOX, C.L., CRNIC, L.S., and PIZER, L.I. (1992). Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant. Virology 187, 348-352.
52. WU, N., WATKINS, S.C., SCHAFFER, P.A., and DELUCA, N. (1996). Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J. Virol. 70, 6358-6369.